Clinical management

Clinical management 100

Orrell C, Hagins DP, Belonosova E, Porteiro N, Walmsley S, Falcó V, et al. Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study. The Lancet HIV 2017.

Clinical management 101

Chirwa M, Ma R, Guallar C, Tariq S. Managing menopause in women living with HIV: A survey of primary care practitioners. Post Reprod Health 2017:2053369117712181.

Clinical management 98

Andany, N. and Walmsley, S.  What's new for antiretroviral treatment in women.  Journal of Virus Eradication.  2016;2:67-77. http://viruseradication.com/journal-details/What's_new_for_antiretroviral_treatment_in_women

Clinical management 97

Bailey H, Thorne C, Malyuta R, et al. Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine. BMC Public Health. 2014;14(1):993. http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-993

Clinical management 96

Best BM, Burchett S, Li H, et al. Pharmacokinetics of tenofovir during pregnancy and postpartum. HIV Med. 2015. http://www.ncbi.nlm.nih.gov/pubmed/25959631

Clinical management 95

Blystad A, Moland KM. Technologies of hope? Motherhood, HIV and infant feeding in eastern Africa. Anthropology & Medicine. 2009;16(2):105-118. http://www.tandfonline.com/doi/abs/10.1080/13648470902940655

Clinical management 94

Boer, K., England, K., Godfried, M.H., et al. (2010) Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe. HIV medicine. European Collaborative Study, [Online] 11 (6), 368–378. Available from: doi:10.1111/j.1468-1293.2009.00800. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428890/

Clinical management 93

Boonyanurak P, Bunupuradah T, Wilawan K, et al. Age at menopause and menopause-related symptoms in human immunodeficiency virus-infected Thai women. Menopause. 2012;19(7):820-824. http://www.ncbi.nlm.nih.gov/pubmed/22549170

Clinical management 99

Bynum, S. A., Wigfall, L. T., Brandt, H. M., Julious, C. H., Glover, S. H., & Hébert, J. R. (2016). Social and Structural Determinants of Cervical Health among Women Engaged in HIV Care. AIDS and Behavior, 1-9. https://www.ncbi.nlm.nih.gov/pubmed/26955821

Clinical management 101

Narasimhan, M., Orza, L., Welbourn, A., Bewley, S., Crone, T. and Vazquez, M. (2016). Sexual and reproductive health and human rights of women living with HIV: a global community survey. Bulletin of the World Health Organization, 94(4), pp.243-249. http://www.who.int/bulletin/volumes/94/4/14-150912.pdf [Accessed 2 Aug 2016]

Clinical management 92

Byrne, L., Fakoya, A. & Harding, K. (2012) HIV in pregnancy: an international perspective: HIV in pregnancy: an international perspective. The Obstetrician &Gynaecologist. [Online] 14 (1), 17–24. Available from: doi:10.1111/j.1744-4667.2011.00076. https://www.researchgate.net/publication/264371391_HIV_in_pregnancy_An_international_perspective

Clinical management 91

Calvet GA, Grinsztejn BG, Quintana Mde S, et al. Predictors of early menopause in HIV-infected women: a prospective cohort study. American journal of obstetrics and gynecology. 2015;212(6):765.e761-765.e713. http://www.ncbi.nlm.nih.gov/pubmed/25557206

Clinical management 90

Calvet GA, Velasque L, Luz PM, et al. Absence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, Brazil. PloS one. 2014;9(2):e89299. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0089299

Clinical management 89

Carlsson-LallooEwa, Rusner Marie, MellgrenÅsa, and Berg Marie. Sexuality and Reproduction in HIV-Positive Women: A Meta-Synthesis.  AIDS Patient Care and STDs. February 2016, 30(2): 56-69. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753620/

Clinical management 88

Carter, M.W., Kraft, J.M., Hatfield-Timajchy, K., Snead, M.C., et al. (2013) The reproductive health behaviors of HIV-infected young women in the United States: A literature review. AIDS patient care and STDs. [Online] 27 (12), 669–680. Available from: doi:10.1089/apc.2013.0208. http://www.ncbi.nlm.nih.gov/pubmed/24320012

Clinical management 87

Cournil, A., Van de Perre, P., Cames, C., de Vincenzi, I., et al. (2015) Early infant feeding patterns and HIV-free survival: findings from the Kesho-Bora trial (Burkina Faso, Kenya, South Africa). The Pediatric Infectious Disease Journal. [Online] 34 (2), 168–174. Available from: doi:10.1097/INF.0000000000000512. http://icrh.org/sites/default/files/00006454-201502000-00013.pdf

Clinical management 86

dePommerol M, Hessamfar M, Lawson-Ayayi S, et al. Menopause and HIV infection: age at onset and associated factors, ANRS CO3 Aquitaine cohort. Int J STD AIDS. 2011;22(2):67-72. http://www.ncbi.nlm.nih.gov/pubmed/21427426

Clinical management 85

deRuiter et al British HIV Association guidelines for the management of HIV infection in pregnant women 2012
(2014 interim review) DOI: 10.1111/hiv.12185 HIV Medicine (2014), 15 (Suppl. 4), 1–77 http://www.bhiva.org/documents/Guidelines/Pregnancy/2012/BHIVA-Pregnancy-guidelines-update-2014.pdf

Clinical management 84

Doherty T, Chopra M, Nkonki L, Jackson D, Greiner T. Effect of the HIV epidemic on infant feeding in South Africa: "When they see me coming with the tins they laugh at me". Bulletin of the World Health Organization. 2006;84:90-96. http://www.ncbi.nlm.nih.gov/pubmed/16501725

Clinical management 83

Ehrhardt S, Xie C, Guo N, Nelson K, Thio CL. Breastfeeding While Taking Lamivudine or TenofovirDisoproxil Fumarate: A Review of the Evidence. Clinical Infectious Diseases. 2015;60(2):275-278. http://cid.oxfordjournals.org/content/early/2014/10/13/cid.ciu798.abstract

Clinical management 82

Elgalib A, Hegazi A, Samarawickrama A, et al. Pregnancy in HIV-infected teenagers in London. HIV Med. 2011;12(2):118-123. http://www.ncbi.nlm.nih.gov/pubmed/20807252

Osteoporosis in postmenopausal women living with HIV

Finnerty F, Walker-Bone K, Tariq S. Osteoporosis in postmenopausal women living with HIV. Maturitas. 2017;95:50-4.

Clinical management 81

Fowler, M., M Qin, SA Fiscus, JS Currier, et al. (2015) PROMISE: Efficacy and Safety of 2 Strategies to Prevent Perinatal HIV Transmission. In: Prevention, Diagnosis and Treatment of Paedatric HIV Infection. 23 February 2015 Seattle, Washington, USA. http://www.croiconference.org/sessions/promise-efficacy-and-safety-2-strategies-prevent-perinatal-hiv-transmission

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, et al. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. N Engl J Med. 2016;375(18):1726-37.

Clinical management 80

French CE, Thorne C, Tariq S, Cortina-Borja M, Tookey PA. Immunologic status and virologic outcomes in repeat pregnancies to HIV-positive women not on antiretroviral therapy at conception: a case for lifelong antiretroviral therapy? AIDS. 2014;28(9):1369-1372. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032213/

Clinical management 79

French C.E. T, P.A., Cortina-Borja, M., de Ruiter, A., Townsend, C.L., Thorne C. Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women. AntivirTher. 2013;18(2):183-192. http://www.ncbi.nlm.nih.gov/pubmed/23475123

Clinical management 78

Gertsch A, Michel O, Locatelli I, et al. Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: a longitudinal electronic monitoring study. AIDS Patient Care STDS. 2013;27(4):208-210. http://www.ncbi.nlm.nih.gov/pubmed/23506310

Clinical management 77

Giles ML, Hellard ME, Lewin SR, O'Brien ML. The "work" of women when considering and using interventions to reduce mother-to-child transmission (MTCT) of HIV. AIDS Care. 2009;21(10):1230-1237. http://www.ncbi.nlm.nih.gov/pubmed/20024698

Clinical management 100

Holstad, M. M., Spangler, S., Higgins, M., Dalmida, S. G., & Sharma, S. (2016). Psychosocial Characteristics Associated with Both Antiretroviral Therapy Adherence and Risk Behaviors in Women Living with HIV. AIDS Behav, 20(5), 1084-1096. http://link.springer.com/article/10.1007/s10461-015-1209-5

Clinical management 76

Homsy, J., Moore, D., Barasa, A., Were, W., et al. (2010) Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). [Online] 53 (1), 28–35. http://www.ncbi.nlm.nih.gov/pubmed/19797972

Clinical management 75

Huntington SE, Thorne C, Bansi LK, et al. Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care at 13 large UK clinics. AIDS. 2013;27(1):95-103. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495056/

Clinical management 74

Huntington SE, Bansi LK, Thorne C, et al. Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception. AIDS. 2011;25(13):1647-1655. http://www.ncbi.nlm.nih.gov/pubmed/21673558

Clinical management 73

Huntington S, Thorne C, Newell M-L, et al. The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy. Aids. 2015;29(17):2269-2278. http://www.ncbi.nlm.nih.gov/pubmed/26544700

Clinical management 72

Huntington S, Thorne C, Newell ML, et al. Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy. AIDS. 2015. http://www.ncbi.nlm.nih.gov/pubmed/25710412

Clinical management 71

ICW Global, GNP+, COWLHA Malawi, and ICW East Africa, (2013). Understanding The Perspectives And/Or Experiences Of Women Living With HIV Regarding Option B+ In Uganda & Malawi In Support Of The Forthcoming Who Consolidated ARV Guidelines. http://www.gnpplus.net/assets/2013-Option-B+-Report-GNP-and-ICW.pdf

HIV-related stigma in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada

Ion A, Wagner AC, Greene S, Loutfy MR. HIV-related stigma in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada. AIDS Care. 2017;29(2):137-44.

Clinical management 69

Kanapathipillai R, Hickey M, Giles M. Human immunodeficiency virus and menopause. Menopause. 2013;20(9):983-990. http://www.ncbi.nlm.nih.gov/pubmed/23531684

Clinical management 68

Katz IT, Shapiro R, Li D, et al. Risk Factors for Detectable HIV-1 RNA at Delivery Among Women Receiving Highly Active Antiretroviral Therapy in the Women and Infants Transmission Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2010;54(1):27-34. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860013/

Clinical management 67

Kelly C, Alderdice F, Lohan M, Spence D. 'Every pregnant woman needs a midwife'-The experiences of HIV affected women in maternity care. Midwifery. 2012;29(2):132-138. http://www.ncbi.nlm.nih.gov/pubmed/23149240

Clinical management 66

Kelly C, Alderdice F, Lohan M, Spence D. Creating continuity out of the disruption of a diagnosis of HIV during pregnancy. Journal of clinical nursing. 2012;21(11-12):1554-1562. http://www.ncbi.nlm.nih.gov/pubmed/22458718

Clinical management 65

Kennedy VL, Serghides L, Raboud JM, et al. The importance of motherhood in HIV-positive women of reproductive age in Ontario, Canada. AIDS Care. 2014;26(6):777-784. http://www.ncbi.nlm.nih.gov/pubmed/24206065

Clinical management 64

Knudsen-Strong, E. From Pregnancy, to Baby and Beyond: Preliminary Findings from an Evaluation of the Pilot Programme, 2011, Positively UK. http://positivelyuk.org/wp-content/uploads/2014/11/Pos-UK-Pregnancy-Project-Evaluation-Report-Aug11.pdf

Clinical management 63

Kourtis, A.P., Schmid, C.H., Jamieson, D.J. & Lau, J. (2007) Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS (London, England). [Online] 21 (5), 607–615. http://www.ncbi.nlm.nih.gov/pubmed/17314523

Clinical management 62

Kulasegaram, A D’Arminio Monforte, J Valdez Madruga, I Krznaric, et al. (2015) Reproductive choices of women with HIV-1 Infection: the ELLA study. In: [Online]. July 2015 Vancouver, Canada. http://pag.ias2015.org/Search/Index

Clinical management 61

Kumar, S., Gruskin, S., Khosla, R. &Narasimhan, M. (2015) Human rights and the sexual and reproductive health of women living with HIV – a literature review. Journal of the International AIDS Society. [Online] 18 (6(Suppl 5)) http://www.jiasociety.org/index.php/jias/article/view/20290/html

Clinical management 60

Looby SE, Shifren J, Corless I, et al. Increased hot flash severity and related interference in perimenopausal human immunodeficiency virus-infected women. Menopause, 2014: 403-9 http://www.ncbi.nlm.nih.gov/pubmed/23820600

Clinical management 59

Looby SE. Menopause-associated metabolic manifestations and symptomatology in HIV infection: a brief review with research implications. J Assoc Nurses AIDS Care. 2012;23(3):195-203. http://www.ncbi.nlm.nih.gov/pubmed/21924646

Clinical management 58

Loutfy MR, Sherr L, Sonnenberg-Schwan U, Walmsley SL, Johnson M, d'Arminio Monforte A. Caring for women living with HIV: gaps in the evidence. J Int AIDS Soc. 2013;16(1):18509. http://www.jiasociety.org/index.php/jias/article/view/18509

Clinical management 57

Lui-Filho JF, Valadares AL, Gomes Dde C, Amaral E, Pinto-Neto AM, Costa-Paiva L. Menopausal symptoms and associated factors in HIV-positive women. Maturitas. 2013;76(2):172-178. http://www.ncbi.nlm.nih.gov/pubmed/23993758

Clinical management 56

Luzuriaga, K. &Mofenson, L.M. (2016) Challenges in the Elimination of Pediatric HIV-1 Infection. New England Journal of Medicine. 374 (8), 761–770. http://www.nejm.org/doi/full/10.1056/NEJMra1505256?af=R&rss=currentIssue

Clinical management 55

Maki PM, Rubin LH, Cohen M, et al. Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse human immunodeficiency virus–infected and human immunodeficiency virus–uninfected women. Menopause. 2012;19(11):1215-1223. http://www.ncbi.nlm.nih.gov/pubmed/22872013

Clinical management 54

Mandelbrot L, Tubiana R, Le Chenadec J, et al. No Perinatal HIV-1 Transmission From Women With Effective Antiretroviral Therapy Starting Before Conception. Clin Infect Dis. 2015;61(11):1715-1725. http://www.ncbi.nlm.nih.gov/pubmed/26197844

Clinical management 53

Marazzi, M.C., Nielsen-Saines, K., Buonomo, E., Scarcella, P., et al. (2009) Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding. The Pediatric Infectious Disease Journal. [Online] 28 (6), 483–487. http://www.ncbi.nlm.nih.gov/pubmed/19483516

Clinical management 52

McDonald K, Kirkman M. HIV-positive women in Australia explain their use and non-use of antiretroviral therapy in preventing mother-to-child transmission. AIDS Care. 2011;23(5):578-584. http://www.ncbi.nlm.nih.gov/pubmed/20824555

Clinical management 51

McFall AM, Dowdy DW, Zelaya CE, et al. Understanding the Disparity: Predictors of Virologic Failure in Women Using Highly Active Antiretroviral Therapy Vary by Race and/or Ethnicity. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2013;64(3):289-298 210.1097/QAI.1090b1013e3182a1095e1099. http://www.ncbi.nlm.nih.gov/pubmed/23797695

Clinical management 50

McKnight, U. & Van der Zaag, A. C. (2015) “When Debility Provides a Future: preventing vertical transmission of HIV”; Journal Article Palgrave Macmillan 2015 11 Fem Rev 111 1 124-139 http://www.palgrave-journals.com/fr/journal/v111/n1/abs/fr201537a.html

Clinical management 102

McLeish, J., & Redshaw, M. (2016). 'We have beaten HIV a bit': a qualitative study of experiences of peer support during pregnancy with an HIV Mentor Mother project in England. BMJ Open, 6(6), e011499. http://bmjopen.bmj.com/content/6/6/e011499

Clinical management 49

Mmeje O, Njoroge B, Cohen CR, Temmerman M, Vermund SH, van der Poel S. Achieving Pregnancy Safely in HIV-Affected Individuals and Couples: An Important Strategy to Eliminate HIV Transmission From Mother-To-Child and Between Sexual Partners. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2015;70(4):e155-e159. http://www.ncbi.nlm.nih.gov/pubmed/26334740

Clinical management 48

Mofenson, L.M., Lambert, J.S., Stiehm, E.R., Bethel, J., et al. (1999) Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. New England Journal of Medicine. 341 (6), 385–393 http://www.ncbi.nlm.nih.gov/pubmed/10432323

Clinical management 47

Momplaisir FM, Brady KA, Fekete T, Thompson DR, Diez Roux A, Yehia BR. Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV. PloS one. 2015;10(7):e0132262. http://www.ncbi.nlm.nih.gov/pubmed/26132142

Clinical management 46

Newell ML, Bunders MJ. Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child. CurrOpin HIV AIDS. 2013;8(5):504-510. http://www.ncbi.nlm.nih.gov/pubmed/23743789

Clinical management 45

Newell, M., Dunn, D., Peckham, C., Semprini, A., et al. (1996) Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European Collaborative Study. AIDS (London, England). 10 (14), 1675–1681 http://www.ncbi.nlm.nih.gov/pubmed/8970688

Clinical management 44

Orza, L., Welbourn, A., Bewley, S., Crone, E. and Vazquez, M. (2015). Building a safe house on firm ground: key findings from a global values and preferences survey regarding the sexual and reproductive health and human rights of women living with HIV.  Salamander Trust. http://salamandertrust.net/resources/BuildingASafeHouseOnFirmGroundFINALreport190115.pdf

Clinical management 43

Panditrao M, Darak S, Jori V, Kulkarni S, Kulkarni V. Barriers associated with the utilization of continued care among HIV-infected women who had previously enrolled in a private sector PMTCT program in Maharashtra, India. AIDS Care. 2015:1-7. http://www.ncbi.nlm.nih.gov/pubmed/25559362

Clinical management 42

Patterson KB, Cohn SE, Uyanik J, Hughes M, Smurzynski M, Eron JJ. Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: an analysis from AIDS Clinical Trials Group Studies. Clin Infect Dis. 2009;49(3):473-476. http://cid.oxfordjournals.org/content/49/3/473.full

Clinical management 41

Paxton, S. (2012). Positive and pregnant: how dare you - A study on access to reproductive and maternal health care for women living with HIV in Asia. Asia Pacific Network of People living with HIV. Available at: http://www.aidsdatahub.org/sites/default/files/documents/positive_and_pregnant_2012.pdf

Clinical management 40

Perry M, Taylor GP, Sabin CA, et al. Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates. HIV Med. 2015. http://www.ncbi.nlm.nih.gov/pubmed/26200570

Clinical management 39

Peters H, Byrne L, De Ruiter A, et al. Duration of ruptured membranes and mother-to-child HIV transmission: a prospective population-based surveillance study. BJOG: An International Journal of Obstetrics & Gynaecology. 2015:n/a-n/a. http://www.ncbi.nlm.nih.gov/pubmed/26011825

Clinical management 38

Phillips SJ, Curtis KM, Polis CB. Effect of hormonal contraceptive methods on HIV disease progression: a Systematic Review. AIDS. 2012. http://www.ncbi.nlm.nih.gov/pubmed/23135169

Clinical management 37

Phillips, S.J., Polis, C.B. & Curtis, K.M. (2016) The safety of hormonal contraceptives for women living with HIV and their sexual partners. Contraception. [Online] 93 (1), 11–16. http://www.ncbi.nlm.nih.gov/pubmed/26515194

Clinical management 36

Perry M, Taylor GP, Sabin CA, et al. Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates. HIV Med. 2015. http://www.ncbi.nlm.nih.gov/pubmed/26200570

Clinical management 35

Peters H, Byrne L, De Ruiter A, et al. Duration of ruptured membranes and mother-to-child HIV transmission: a prospective population-based surveillance study. BJOG: An International Journal of Obstetrics & Gynaecology. 2015:n/a-n/a. http://www.ncbi.nlm.nih.gov/pubmed/26011825

Clinical management 34

Phillips SJ, Curtis KM, Polis CB. Effect of hormonal contraceptive methods on HIV disease progression: a Systematic Review. AIDS. 2012. http://www.ncbi.nlm.nih.gov/pubmed/23135169

Clinical management 33

Phillips, S.J., Polis, C.B. & Curtis, K.M. (2016) The safety of hormonal contraceptives for women living with HIV and their sexual partners. Contraception. [Online] 93 (1), 11–16. http://www.ncbi.nlm.nih.gov/pubmed/26515194

Clinical management 32

Polis CB, Phillips SJ, Curtis KM. Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence. AIDS. 2013;27(4):493-505. http://www.sciencedirect.com/science/article/pii/S001078241400571X

Clinical management 31

Powis, K.M., Kitch, D., Ogwu, A., Hughes, M.D., et al. (2011) Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor-Based HAART During Pregnancy. Journal of Infectious Diseases. [Online] 204 (4), 506–514. http://www.ncbi.nlm.nih.gov/pubmed/21791651

Clinical management 30

Psaros C, Remmert JE, Bangsberg DR, Safren SA, Smit JA. Adherence to HIV Care After Pregnancy Among Women in Sub-Saharan Africa: Falling Off the Cliff of the Treatment Cascade. Current HIV/AIDS Reports. 2015:1-5. http://www.ncbi.nlm.nih.gov/pubmed/25620530

Clinical management 29

Rachas A, Warszawski J, Le Chenadec J, et al. Does pregnancy affect the early response to cART? AIDS. 2013;27(3):357-367. http://www.ncbi.nlm.nih.gov/pubmed/23079802

Clinical management 28

Rahangdale L, Stewart A, Stewart RD, et al. Pregnancy Intentions Among Women Living With HIV in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2014;65(3):306-311 310.1097/QAI.0000000000000014. http://www.ncbi.nlm.nih.gov/pubmed/24525467

Clinical management 27

Read, J.S. & Newell, M.-L. (2005) Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. In: The Cochrane Collaboration (ed.). Cochrane Database of Systematic Reviews. http://apps.who.int/rhl/reviews/langs/CD005479.pdf

Clinical management 26

Rosin C, Elzi L, Thurnheer C, et al. Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study. HIV Med. 2014. http://www.ncbi.nlm.nih.gov/pubmed/25329751

Clinical management 25

Rubin LH, Sundermann EE, Cook JA, et al. Investigation of menopausal stage and symptoms on cognition in human immunodeficiency virus-infected women. Menopause. 2014;21(9):997-1006. http://www.ncbi.nlm.nih.gov/pubmed/24496085

Clinical management 24

Salamander Trust, (2014). Salamander Trust values and preferences survey: sexual and reproductive health and human rights for women living with HIV http://salamandertrust.net/resources/SalamanderSRHRWHOSurveyforCirculationENGLISHMay2014.pdf

Clinical management 23

Sanders LB. Women's voices: the lived experience of pregnancy and motherhood after diagnosis with HIV. J Assoc Nurses AIDS Care. 2008;19(1):47-57. http://www.ncbi.nlm.nih.gov/pubmed/18191768

Clinical management 22

Saunders P, Goodman AL, Smith CJ, et al. Does gender or mode of HIV acquisition affect virological response to modern antiretroviral therapy (ART)? HIV Med 2015. http://www.ncbi.nlm.nih.gov/pubmed/26140659

Clinical management 21

Scherzer R, Bacchetti P, Messerlian G, et al. Impact of CD4+ lymphocytes and HIV infection on Anti-Mullerian Hormone levels in a large cohort of HIV-infected and HIV-uninfected women. Am J ReprodImmunol. 2015;73(3):273-284. http://www.ncbi.nlm.nih.gov/pubmed/25339186

Clinical management 20

Shapiro, R.L., Hughes, M.D., Ogwu, A., Kitch, D., et al. (2010) Antiretroviral regimens in pregnancy and breast-feeding in Botswana. New England Journal of Medicine. 362 (24), 2282–2294. http://www.nejm.org/doi/full/10.1056/NEJMoa0907736

Sherr L, Molloy A, Macedo A, Croome N, Johnson MA. Ageing and menopause considerations for women with HIV in the UK. Journal of Virus Eradication. 2016;2(4):215-8.

Clinical management 19

Short, C.-E.S. & Taylor, G.P. (2014) Antiretroviral therapy and preterm birth in HIV-infected women. Expert Review of Anti-infective Therapy. [Online] 12 (3), 293–306. http://onlinelibrary.wiley.com/doi/10.1111/hiv.12083/abstract

Clinical management 18

Squires et al. WAVES, Elvitegravir (EVG)/Cobicistat (COBI)/Emtricitabine (FTC)/TenofovirDisoproxil Fumarate (TDF) Is Superior to Ritonavir (RTV)‒Boosted Atazanavir (ATV) Plus FTC/TDF in Treatment-Naïve Women With HIV-1 Infection (WAVES Study). http://pag.ias2015.org/Abstract/AbstractDetail/3557

Clinical management 17

Tariq S, Pillen A, Tookey PA, Brown AE, Elford J. The impact of African ethnicity and migration on pregnancy in women living with HIV in the UK: design and methods. BMC Public Health. 2012;12(1):596. http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-12-596

Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women

Squires K, Kityo C, Hodder S, Johnson M, Voronin E, Hagins D, et al. Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study. The Lancet HIV. 2016;3(9):e410-e20.

Clinical management 16

Tariq S, Elford J, Cortina-Borja M, Tookey PA, On Behalf Of The National Study Of HIV in Pregnancy and Childhood. The association between ethnicity and late presentation to antenatal care among pregnant women living with HIV in the UK and Ireland. AIDS Care. 2012;28(8):978-985. http://www.ncbi.nlm.nih.gov/pubmed/22519823

Clinical management 15

Tariq S, Townsend CL, Cortina-Borja M, et al. Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009. J Acquir Immune DeficSyndr. 2011;57(4):326-333. http://www.ncbi.nlm.nih.gov/pubmed/21499113

Clinical management 14

Tariq, S., Elford, J., Tookey, P., Anderson, J., de Ruiter, A., O'Connell, R., &Pillen, A. (2016). “It pains me because as a woman you have to breastfeed your baby”: decision-making about infant feeding among African women living with HIV in the UK. Sexually transmitted infections, 2015. http://www.ncbi.nlm.nih.gov/pubmed/26757986

Clinical management 13

Tariq, S et al.  (2016).  The menopause transition in women living with HIV: current evidence and future avenues of research.  Journal of virus eradication. http://viruseradication.com/journal-details/The_menopause_transition_in_women_living_with_HIV:_current_evidence_and_future_avenues_of_research/

Clinical management 12

Tariq, S et al.  (2016).  The impact of the menopause transition on the health and wellbeing of women living with HIV: a narrative review.  Maturitas. 2016; 88:76-83. http://www.sciencedirect.com/science/article/pii/S0378512216300640

Clinical management 11

Taylor, G.P., Trust, U.K., Positively, U.K. & Trust, L. (2010) Position statement on infant feeding in the UK.British HIV Association (BHIVA) and Children’s HIV Association (CHIVA) http://chiva.org.uk/professionals/health/guidelines/mtct/feeding-statement

Clinical management 70

The International Perinatal HIV Group (1999) The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med 1999; 340:977-987 http://www.nejm.org/doi/full/10.1056/NEJM199904013401301

Clinical management 10

Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA. Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990-2006. BJOG. 2008;115(9):1078-1086. http://www.ncbi.nlm.nih.gov/pubmed/18503577

Clinical management 9

Townsend CL, Byrne L, Cortina-Borja M, et al. Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011. AIDS. 2014;28(7):1049-1057. http://www.ncbi.nlm.nih.gov/pubmed/24566097

Clinical management 8

Townsend, C.L., Cortina-Borja, M., Peckham, C.S. &Tookey, P.A. (2007) Response to Kourtis et al. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS 21 (13), 1831–1832. http://journals.lww.com/aidsonline/fulltext/2007/08200/response_to_kourtis_et_al___use_of_antiretroviral.27.aspx

Clinical management 7

Townsend, C., Schulte, J., Thorne, C., Dominguez, K., et al. (2010) Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe. BJOG: An International Journal of Obstetrics &Gynaecology. [Online] 117 (11), 1399–1410. http://www.ncbi.nlm.nih.gov/pubmed/20716250

Clinical management 6

Treisman K, Jones FW, Shaw E. The experiences and coping strategies of United Kingdom-based African women following an HIV diagnosis during pregnancy. J Assoc Nurses AIDS Care. 2014;25(2):145-157. http://www.ncbi.nlm.nih.gov/pubmed/23523367

Clinical management 5

UNAIDS. Joint United Nations Programme on HIV/AIDS (2011) Countdown to zero: global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive, 2011-2015. Geneva, Switzerland, UNAIDS http://www.unaids.org/sites/default/files/media_asset/20110609_JC2137_Global-Plan-Elimination-HIV-Children_en_1.pdf

Clinical management 4

vanBenthem BH, Vernazza P, Coutinho RA, Prins M. The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women. AIDS. 2002;16(6):919-924. http://www.ncbi.nlm.nih.gov/pubmed/11919494

Clinical management 3

Wall KM et al. Hormonal contraception, pregnancy, breastfeeding and risk of HIV disease progression among Zambian women. J Acquir Immune DeficSyndr. 2015 Sep 12. http://www.ncbi.nlm.nih.gov/pubmed/26379070

Clinical management 2

Wedi COO, Kirtley S, Hopewell S, Corrigan R, Kennedy SH, Hemelaar J. Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis. The Lancet HIV. 2015. http://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(15)00207-6/abstract

Clinical management 1

Yalamanchi S, Dobs A, Greenblatt RM. Gonadal function and reproductive health in women with human immunodeficiency virus infection. EndocrinolMetabClin North Am. 2014;43(3):731-741. http://www.ncbi.nlm.nih.gov/pubmed/25169564

Engagement in care

Puskas, Cathy M.; Kaida, Angela; Miller, Cari L.; Zhang, Wendy; Yip, Benita; Pick, Neora; Montaner, Julio S.G.; Hogg, Robert S. The gender gap: a longitudinal examination of men's and women's art adherence in british columbia, 2000-2014. AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001408 - https://www.ncbi.nlm.nih.gov/pubmed/28118206 

Engagement in Care 28

Kronfli N, Lacombe-Duncan A, Wang Y, de Pokomandy A, Kaida A, Logie C, et al. Access and engagement in HIV care among a national cohort of women living with HIV in Canada. AIDS Care 2017; 29(10):1235-1242.

Engagement in care 27

Aebi-Popp K, Kouyos R, Bertisch B, et al. Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period. HIV Med. 2015. http://www.ncbi.nlm.nih.gov/pubmed/26268702

Engagement in care 26

Adams JW, Brady KA, Michael YL, Yehia BR, Momplaisir FM. Postpartum Engagement in HIV Care: An Important Predictor of Long Term Retention in Care and Viral Suppression. Clin Infect Dis. 2015;61(12):1880-1887. http://cid.oxfordjournals.org/content/early/2015/08/10/cid.civ678

Engagement in care 25

Anderson J, Doyal L. Women from Africa living with HIV in London: a descriptive study. AIDS Care. 2004;16(1):95-105. http://www.ncbi.nlm.nih.gov/pubmed/14660147

Engagement in care 24

Anderson J, Doyal L. Women from Africa living with HIV in London: a descriptive study. AIDS Care. 2004;16(1):95-105. http://www.ncbi.nlm.nih.gov/pubmed/14660147

Engagement in care 23

ATHENA Network . In Women's Words: HIV Priorities for positive change. (2011) http://wecareplus.net/resources/InWomen%27sWordsFinal.pdf

Engagement in care 22

AVAC, ATHENA, Salamander Trust, AVAC, ATHENA. UNWomen, (2015). Key barriers to women’s access to HIV treatment: Making “Fast-Track” a reality. http://salamandertrust.net/resources/web_UNWomenetal_IAS%20treatment_access-4pp.pdf

Engagement in care 28

Bengtson, A. M., Chibwesha, C. J., Westreich, D., Mubiana-Mbewe, M., Chi, B. H., Miller, W. C., . . . Pettifor, A. (2016). A risk score to identify HIV-infected women most likely to become lost to follow-up in the postpartum period. AIDS Care, 28(8), 1035-1045. https://www.ncbi.nlm.nih.gov/pubmed/26887526

Engagement in care 21

Blackstock OJ, Blank AE, Fletcher JJ, Verdecias N, Cunningham CO. Considering Care-Seeking Behaviors Reveals Important Differences Among HIV-Positive Women Not Engaged in Care: Implications for Intervention. AIDS Patient Care and STDs. 2015;29(S1):S20-S26. http://www.ncbi.nlm.nih.gov/pubmed/25561307

Engagement in care 20

Blais M, Fernet M, Proulx-Boucher K, et al. Barriers to health-care and psychological distress among mothers living with HIV in Quebec (Canada). AIDS Care. 2015:1-8. http://www.ncbi.nlm.nih.gov/pubmed/25587793

Engagement in care 19

Blank AE, Fletcher J, Verdecias N, Garcia I, Blackstock O, Cunningham C. Factors Associated with Retention and Viral Suppression Among a Cohort of HIV+ Women of Color. AIDS Patient Care STDS. 2014. http://www.ncbi.nlm.nih.gov/pubmed/25458205

Engagement in care 18

Boehme AK, Davies SL, Moneyham L, Shrestha S, Schumacher J, Kempf MC. A qualitative study on factors impacting HIV care adherence among postpartum HIV-infected women in the rural southeastern USA. AIDS Care. 2013. http://www.ncbi.nlm.nih.gov/pubmed/24116662

Engagement in care 17

Buchberg MK, Fletcher FE, Vidrine DJ, et al. A mixed-methods approach to understanding barriers to postpartum retention in care among low-income, HIV-infected women. AIDS Patient Care STDS. 2015;29(3):126-132. http://www.ncbi.nlm.nih.gov/pubmed/25612217

Engagement in care 16

Clouse K, Pettifor A, Shearer K, et al. Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa. Tropical medicine & international health : TM & IH. 2013. http://www.ncbi.nlm.nih.gov/pubmed/23374278

Engagement in care 15

Dilmitis, S., Edwards, O., Hull, B., Margolese, S., Mason, N., Namiba, A., Nyambe, M., Paxton, S., Petretti, S., Ross, G., Welbourn, A. and Zakowics, A. (2012). Language, identity and HIV: why do we keep talking about the responsible and responsive use of language? Language matters. Journal of the International AIDS Society, 15(4(Suppl 2). http://www.jiasociety.org/index.php/jias/article/view/17990

Engagement in care 14

Doyal, Lesley, and Jane Anderson. “HIV-positive African Women Surviving in London: Report of a Qualitative Study”. Gender and Development 14 (1): 95–104. 2006 http://www.jstor.org/stable/20461119

Engagement in care 13

Doyal L, Anderson J'My fear is to fall in love again...' How HIV-positive African women survive in London. SocSci Med. 2005 Apr;60(8):1729-38. http://www.ncbi.nlm.nih.gov/pubmed/15686805

Engagement in care 12

Ferguson L, Lewis J, Grant AD, et al. Patient Attrition Between Diagnosis With HIV in Pregnancy-Related Services and Long-Term HIV Care and Treatment Services in Kenya: A Retrospective Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2012;60(3):e90-e97. http://www.ncbi.nlm.nih.gov/pubmed/22421747

Engagement in care 11

Jasseron C, Mandelbrot L, Tubiana R, et al. Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women? AIDS. 2008;22(12):1503-1511. http://www.ncbi.nlm.nih.gov/pubmed/18614874

Engagement in care 10

Johnson M, Samarina A, Xi H, et al. Barriers to access to care reported by women living with HIV across 27 countries. AIDS Care. 2015:1-11. http://www.ncbi.nlm.nih.gov/pubmed/26168817

Engagement in care 9

Lambert JS, Avramovic G, Jackson V, Sammon N, Lally S, Campbell FJ. Investigation Into the Reasons for Maternal Default from HIV Care Postpartum: A 3-Year Retrospective Review. AIDS Patient Care STDS. 2014;28(1):1-3. http://www.ncbi.nlm.nih.gov/pubmed/24380437

Engagement in care 8

Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012;26(16):2039-2052. http://www.ncbi.nlm.nih.gov/pubmed/22951634

Engagement in care 7

Oron, B., Sebuwufu, G. and Welbourn, A. (2014). Stepping Stones for Peace and Prosperity. Strategies for Hope Trust and Salamander Trust. http://www.steppingstonesfeedback.org/index.php/page/Resources/gb?resourceid=79

Engagement in care 6

Paine, K., Hart, G., Jawo, M., Ceesay, S., Jallow, M., Morison, L., Walraven, G., McAdam, K. and Shaw, M. (2002). “˜Before we were sleeping, now we are awake”: Preliminary evaluation of the Stepping Stones sexual health programme in The Gambia. African Journal of AIDS Research, 1(1), pp.39-50. http://siteresources.worldbank.org/INTGENDER/Resources/MatthewShawAJARarticle.pdf

Engagement in care 5

Phillips T, Thebus E, Bekker LG, McIntyre J, Abrams EJ, Myer L. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study. J Int AIDS Soc. 2014;17(1):19242. http://www.ncbi.nlm.nih.gov/pubmed/25301494

Engagement in care 4

Positively UK, Women know best report, 24.9.2015 http://positivelyuk.org/women-know-best/

Engagement in care 3

Siddiqui R, Bell T, Sangi-Haghpeykar H, Minard C, Levison J. Predictive factors for loss to postpartum follow-up among low income HIV-infected women in Texas. AIDS Patient Care STDS. 2014;28(5):248-253. http://www.ncbi.nlm.nih.gov/pubmed/24720630

Engagement in care 2

Tariq S, Elford J, Cortina-Borja M, Tookey PA, On Behalf Of The National Study Of HIV in Pregnancy and Childhood. The association between ethnicity and late presentation to antenatal care among pregnant women living with HIV in the UK and Ireland. AIDS Care. 2012;28(8):978-985. http://www.ncbi.nlm.nih.gov/pubmed/22519823

Engagement in care1

Tariq, S., Elford, J., Chau, C., French, C., Cortina-Borja, M., Brown, A., Tookey, P. A. (2016). Loss to Follow-Up After Pregnancy Among Sub-Saharan Africa-Born Women Living With Human Immunodeficiency Virus in England, Wales and Northern Ireland: Results From a Large National Cohort. Sex Transm Dis, 43(5), 283-289. https://www.ncbi.nlm.nih.gov/pubmed/27100763

Engagement in care 1

Tenthani L, Haas AD, Tweya H, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi. AIDS. 2014;28(4):589-598. http://www.ncbi.nlm.nih.gov/pubmed/24468999

Engagement in care2

Welbourn A, Orza L, Bewley S, Crone ET, Vazquez M, 2016 Sometimes you feel like you have no choice but to bear with it all” How much do we understand side-effects of ARVs on lives of women living with HIV? Poster. International AIDS Conference, Durban http://salamandertrust.net/wp-content/uploads/2014/05/SalamanderTrustAIDS2016__poster_finalTUPED272.pdf

Engagement in research

Engagement in research 11

Bucholz EM, Krumholz HM. Women in clinical research: what we need for progress. CircCardiovascQual Outcomes. 2015;8(2 Suppl 1):S1-3. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415379/

Engagement in research 10

Corneli AL et al. The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills. J Acquir Immune DeficSyndr. 2015 Apr 15;68(5):578-84. http://www.ncbi.nlm.nih.gov/pubmed/25761233

Engagement in research 9

Curno MJ, Rossi S, Hodges-Mameletzis I, Johnston R, Price MA, Heidari S. A Systematic Review of the Inclusion (or Exclusion) of Women in HIV Research: From Clinical Studies of Antiretrovirals and Vaccines to Cure Strategies. JAIDS. 2016;71(2):181-188. http://www.ncbi.nlm.nih.gov/pubmed/26361171

Engagement in research 8

Dilmitis, S., Edwards, O., Hull, B., Margolese, S., Mason, N., Namiba, A., Nyambe, M., Paxton, S., Petretti, S., Ross, G., Welbourn, A. and Zakowics, A. (2012). Language, identity and HIV: why do we keep talking about the responsible and responsive use of language? Language matters. Journal of the International AIDS Society, 15(4(Suppl 2). http://www.jiasociety.org/index.php/jias/article/view/17990

Engagement in research 7

ICW. Guidelines on ethical participatory research with HIV positive women. (2004). http://www.hivlawandpolicy.org/resources/guidelines-ethical-participatory-research-hiv-postive-women-international-community-women

Engagement in research 6

Loutfy MR, Sherr L, Sonnenberg-Schwan U, Walmsley SL, Johnson M, d'Arminio Monforte A. Caring for women living with HIV: gaps in the evidence. J Int AIDS Soc. 2013;16(1):18509. http://www.jiasociety.org/index.php/jias/article/view/18509

Engagement in research 12

Namiba, A, Orza, L, Bewley, S, Tyler Crone, E, Vazquez, M, Wellbourn, A.  Ethical, strategic and meaningful involvement of women living with HIV starts at the beginning.  Journal of Virus Eradication.  2016;2: 119-111. http://viruseradication.com/journal-details/Ethical,_strategic_and_meaningful_involvement_of_women_living_with_HIV_starts_at_the_beginning

Engagement in research 5

Namiba, A., Orza, L., Bewley, S., Crone, T., Vazquez, M. and Welbourn, A. (n.d.). “Welcome to our house”: The meaningful involvement of women living with HIV in WHO guideline development starts simply - at the beginning. Journal of Virus Eradication 2, 110-111.

http://viruseradication.com/journal-details/Ethical,_strategic_and_meaningful_involvement_of_women_living_with_HIV_starts_at_the_beginning/ 

Engagement in research 4

Narasimhan, M., Orza, L., Welbourn, A., Bewley, S., Crone, E. and Vazquz, M. (2015). Ensuring users values and preferences in WHO guidelines:  Sexual and reproductive health and human rights of women living with HIV. http://www.jiasociety.org/index.php/jias/article/view/20290/html

Engagement in research 3

Positively UK, Women know best report, 24.9.2015 http://positivelyuk.org/women-know-best/

Engagement in research 2

Welbourn, A. (2014). WHO's poor consultation with patients on HIV guidance has denied women choice in drug treatment. BMJ, 348(2007), pp.f7601-f7601. http://www.bmj.com/content/348/bmj.f7601

Engagement in research 1

Westreich D, Rosenberg M, Schwartz S, Swamy G. Representation of women and pregnant women in HIV research: a limited systematic review. PloS one. 2013;8(8):e73398. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751870/

Gender-based violence

The Concept and Measurement of Violence against Women and Men

S. Walby, J. Towers, S Balderston, C Corradi, B Francis, M Heiskanen, K Helweg-Larsen, L Mergaert, P Olive, E Palmer, H Stöckl and S Strid, The Concept and Measurement of Violence against Women and Men, 14 Feb 2017, PDF available at: https://policypress.co.uk/the-concept-and-measurement-of-violence-against-women-and-men

A New Methodology to Measure Repeat Attacks Making Visible the Significance of Gender and Domestic Relations

Sylvia Walby, Jude Towers and Brian Francis , Is Violent Crime Increasing or Decreasing? A New Methodology to Measure Repeat Attacks Making Visible the Significance of Gender and Domestic Relations, Br J Criminol (2016) 56 (6): 1203-1234. DOI: https://doi.org/10.1093/bjc/azv131https://academic.oup.com/bjc/article/56/6/1203/2415172/Is-Violent-Crime-Increasing-or-Decreasing-a-New

Screening for intimate partner violence in a London HIV clinic

Madge, S., Smith, C., Warren-Gash, C., Bayly, J., & Bartley, A. (2017). Screening for intimate partner violence in a London HIV clinic: characteristics of those screening positive. HIV Med, 18(1), 66-68. doi:10.1111/hiv.12404, https://www.ncbi.nlm.nih.gov/pubmed/27905674

Gender-based violence 22

AIDS Legal Network. If I knew what would happen I would have kept it to myself: Gender violence and HIV. (2012). http://www.endvawnow.org/uploads/browser/files/gender_violence_hiv__report_summary.pdf

Gender-based violence 21

AVAC, ATHENA, Salamander Trust, UNWomen, (2015). Key barriers to women’s access to HIV treatment: Making ‘Fast-Track’ a reality.

http://salamandertrust.net/wp-content/uploads/2015/07/UNWomenetal_Web_Treatment_access_4pp2016_Final.pdf 

Gender-based violence 20

Campbell, J., Baty, M., Ghandour, R., Stockman, J., Francisco, L. and Wagman, J. (2008). The intersection of intimate partner violence against women and HIV/AIDS: a review. International Journal of Injury Control and Safety Promotion, 15(4), pp.221-231. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274697/

Gender-based violence 19

Bradley, J., Bhattacharjee, P., Ramesh, B., Girish, M. and Das, A. Evaluation of Stepping Stones as a tool for changing knowledge, attitudes and behaviours associated with gender, relationships and HIV risk in Karnataka, India. 2011 BMC Public Health, 11(1) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146862/

Gender-based violence 18

Dhairyawan R et al. Intimate partner violence in women living with HIV attending an inner city clinic in the UK: prevalence and associated factors. HIV Medicine, Volume 14, Issue 5, pages 303–310, May 2013. http://onlinelibrary.wiley.com/doi/10.1111/hiv.12009/full

Gender-based violence 17

Durevall, D. and Lindskog, A. (2015). Intimate partner violence and HIV in ten sub-Saharan African countries: what do the Demographic and Health Surveys tell us?.The Lancet Global Health, 3(1), pp.e34-e43. http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(14)70343-2/fulltext?rss=yes

Gender-based violence 16

Hale, F. and Vazquez, M. (2011). Violence Against Women living with HIV/AIDS: A Background Paper. Development Connections and ICW with the Support of UNWomen.

http://salamandertrust.net/wp-content/uploads/2012/12/VAPositiveWomenBkgrdPaperMarch2011.pdf 

Gender-based violence 15

Hatcher, A., Smout, E., Turan, J., Christofides, N. and Stoeckl, H. (2015). Intimate partner violence and engagement in HIV care and treatment among women. AIDS, p.1. http://www.ncbi.nlm.nih.gov/pubmed/26353027

Gender-based violence 14

Human Rights Watch.Hidden in the mealie meal: Gender-Based Abuses and Women’s HIV Treatment in Zambia. (2007) https://www.hrw.org/sites/default/files/reports/zambia1207web.pdf

Gender-based violence 13

Hutchinson, J. and Perry, G. (2012). Violence as a cause and consequence of women living with HIV in England. Sophia Forum.

http://sophiaforum.net/wp-content/uploads/2013/02/Finalweb_SophiaForum_HIV_GBVreport2013.pdf

Gender-based violence 23

Ion, A., Wagner, A. C., Greene, S., Loutfy, M. R., & Team, H. I. V. M. S. (2016). HIV-related stigma in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada. AIDS Care, 1-8. https://www.ncbi.nlm.nih.gov/pubmed/27449254

Gender-based violence 12

Li, Y., Marshall, C., Rees, H., Nunez, A., Ezeanolue, E. and Ehiri, J. Intimate partner violence and HIV infection among women: a systematic review and meta-analysis.2014, Journal of the International AIDS Society, 17(1). http://www.jiasociety.org/index.php/jias/article/view/18845

Gender-based violence 11

Mwanza, J. (2012). Baseline report on intimate partner violence amongst people living with HIV. COWLHA Malawi. http://steppingstonesfeedback.org/resources/25/IPVCOWLHAREPORTFINAL.pdf

Gender-based violence 10

Orza, L., Bewley, S., Chung, C., Crone, E., Nagadya, H., Vazquez, M. and Welbourn, A. (2015). “Violence. Enough already”: findings from a global participatory survey among women living with HIV. Journal of the International AIDS Society, 18(Suppl 5). http://www.jiasociety.org/index.php/jias/article/view/20285

Gender-based violence 9

 

Orza, L., Welbourn, A., Bewley, S., Crone, E. and Vazquez, M. (2015). Building a safe house on firm ground: key findings from a global values and preferences survey regarding the sexual and reproductive health and human rights of women living with HIV. Salamander Trust.

http://salamandertrust.net/wp-content/uploads/2014/05/BuildingASafeHouseOnFirmGroundFINALreport190115.pdf

Gender-based violence 8

Osinde, M., Kaye, D. and Kakaire, O. (2011). Intimate partner violence among women with HIV infection in rural Uganda: critical implications for policy and practice. BMC Women's Health, 11(1), p.50. http://bmcwomenshealth.biomedcentral.com/articles/10.1186/1472-6874-11-50

Gender-based violence 7

Paxton, S. (2012). Positive and pregnant: how dare you - A study on access to reproductive and maternal health care for women living with HIV in  Asia.  Asia Pacific Network of People living with HIV. http://www.aidsdatahub.org/sites/default/files/documents/positive_and_pregnant_2012.pdf 

Gender-based violence 6

Stadler J et al Hidden harms: Women's narratives of intimate partner violence in a microbicide trial, South Africa. Social Science & Medicine 2014 June; Volume 110, pp. 49–55 http://www.sciencedirect.com/science/article/pii/S0277953614001907

Gender-based violence 5

Welbourn, A. (2014). WHO's poor consultation with patients on HIV guidance has denied women choice in drug treatment. BMJ, 348(2007), pp.f7601-f7601. http://www.bmj.com/content/348/bmj.f7601

Gender-based violence 4

16 ideas for addressing violence against women in the context of the HIV epidemic: a programming tool. (2013). Geneva: WHO/UNAIDS. Available at: http://apps.who.int/iris/bitstream/10665/95156/1/9789241506533_eng.pdf

Gender-based violence 3

WHO, Global and regional estimates of violence against women: prevalence and health effects of intimate partner violence and non-partner sexual violence. (2013). http://apps.who.int/iris/bitstream/10665/85239/1/9789241564625_eng.pdf?ua=1

Gender-based violence 2

WHO Intimate Partner Violence during pregnancy: information sheet. (2011) WHO. http://whqlibdoc.who.int/hq/2011/WHO_RHR_11.35_eng.pdf

Gender-based violence 1

Willie, T., Overstreet, N., Sullivan, T., Sikkema, K. and Hansen, N. (2015). Barriers to HIV Medication Adherence: Examining Distinct Anxiety and Depression Symptoms among Women Living with HIV Who Experienced Childhood Sexual Abuse. Behavioral Medicine, pp.00-00. http://www.ncbi.nlm.nih.gov/pubmed/26010763

HIV prevention

HIV Prevention

Heffron R, McClelland RS, Balkus JE, Celum C, Cohen CR, Mugo N, et al. Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study. The Lancet HIV 2017.

HIV Prevention 18

Auerbach JD, Kinsky S, Brown G, Charles V. Knowledge, Attitudes, and Likelihood of Pre-Exposure Prophylaxis (PrEP) Use Among US Women at Risk of Acquiring HIV. AIDS patient care and STDs. 2014. http://www.ncbi.nlm.nih.gov/pubmed/25513954

HIV Prevention 17

Baeten, J.M., Donnell, D., Ndase, P., Mugo, N.R., et al. (2012) Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women. New England Journal of Medicine. [Online] 367 (5), 399–410. Available from: doi:10.1056/NEJMoa1108524. http://www.ncbi.nlm.nih.gov/pubmed/22784037

HIV Prevention 16

Bradley, J., Bhattacharjee, P., Ramesh, B., Girish, M. and Das, A. Evaluation of Stepping Stones as a tool for changing knowledge, attitudes and behaviours associated with gender, relationships and HIV risk in Karnataka, India. 2011 BMC Public Health, 11(1) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146862/

HIV Prevention 15

Chitembo, A., Dilmitis, S., Edwards, O., Foote, C., Griffiths, L., Moroz, S., Mungherera, L., Mworeko, L., Manchester, J., Margolese, S., Namiba, A., Paxton, S., Ross, G., Shahi, S. and Welbourn, A. (2012). Towards an HIV-free generation: getting to zero or getting to rights? Reproductive Health Matters, 20(39), pp.5-13. http://www.ncbi.nlm.nih.gov/pubmed/23177675

HIV Prevention 14

Corneli AL et al. The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills. J Acquir Immune DeficSyndr. 2015 Apr 15;68(5):578-84. http://www.ncbi.nlm.nih.gov/pubmed/25761233

HIV Prevention 13

Doggett EG et al. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction Journal of the International AIDS Society 2015, 18:20536 http://www.jiasociety.org/index.php/jias/article/view/20536

HIV Prevention 12

Gafos M et al. Intravaginal insertion in KwaZulu-Natal sexual practices and preferences in the context of microbicide gel use, Culture, Health and Sexuality, Volume 12 Issue 8, 2010, http://dx.doi.org/10.1080/13691058.2010.507876

HIV Prevention20

Grant, R. M., Sevelius, J. M., Guanira, J. V., Aguilar, J. V., Chariyalertsak, S., & Deutsch, M. B. (2016). Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis. Journal of acquired immune deficiency syndromes (1999), 72(Suppl 3), S226. https://www.ncbi.nlm.nih.gov/pubmed/27429187

HIV Prevention 11

Jewkes, R., Nduna, M., Levin, J., Jama, N., Dunkle, K., Puren, A. and Duvvury, N. (2008). Impact of Stepping Stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ, 337(aug07 1), pp.a506-a506. http://www.bmj.com/content/337/bmj.a506

HIV Prevention 10

Karim QA., Salim S. Karim, Frohlich, J.A., Grobler, A.C., et al. (2010) Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women. Science [Online] 329 (5996), 1168–1174. Available from: doi:10.1126/science.1193748. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001187/

HIV Prevention 9

Marrazzo JM et al. Tenofovir-based pre-exposure prophylaxis for HIV infection among African women. N Engl J Med 372(6): 509-518. 2015. http://www.nejm.org/doi/full/10.1056/NEJMoa1402269

HIV Prevention 8

Montgomery C et al. Reframing microbicide acceptability: findings from the MDP301 Trial, Culture Health and Sexuality 2010 12: 6, 649-662 http://dx.doi.org/10.1080/13691051003736261

HIV Prevention 7

Ngure Kenneth, Heffron Renee, Curran Kathryn, Vusha Sophie, Ngutu Mariah, Mugo Nelly, Celum Connie, and Baeten Jared M. I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation. AIDS Patient Care and STDs. February 2016, 30(2): 78-83. doi:10.1089/apc.2015.0259. http://online.liebertpub.com/doi/abs/10.1089/apc.2015.0259

HIV Prevention 6

Philpott A. et al (2006) ‘Pleasure and Prevention: when good sex is safe sex’ Reproductive Health Matters 14(28):23–31 https://secure.jbs.elsevierhealth.com/action/showCitFormats?pii=S0968-8080%2806%2928254-5&doi=10.1016%2FS0968-8080%2806%2928254-5&code=rhm-site

HIV prevention1

Sevelius, J. M., Keatley, J., Calma, N., & Arnold, E. (2016). 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health, 11(7-8), 1060-1075. doi:10.1080/17441692.2016.1154085 https://www.ncbi.nlm.nih.gov/pubmed/26963756

HIV Prevention 5

Stadler, J. &Saethre, E. ‘Blockage and Flow: intimate experiences of condoms and microbicides in a South African Clinical trial’ in Culture, Health and Sexuality , 2011 , 13(1): 31-44 http://www.academia.edu/13510248/Blockage_and_flow_intimate_experiences_of_condoms_and_microbicides_in_a_South_African_clinical_trial

HIV Prevention 4

Stadler J et al Hidden harms: Women's narratives of intimate partner violence in a microbicide trial, South Africa. Social Science & Medicine 2014 June; Volume 110, pp. 49–55 http://www.sciencedirect.com/science/article/pii/S0277953614001907

HIV Prevention 3

Syvertsen JL et al. Promise and Peril of Pre-Exposure Prophylaxis (PrEP): Using Social Science to Inform PrEP Interventions among Female Sex Workers. African Journal of Reproductive Health 2014 Sep; 18(3 0 0): 74–83. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605136/

HIV Prevention 2

The Pleasure Project, The global mapping of pleasure, 2004 http://thepleasureproject.org/downloads/GM_Final.pdf 

HIV Prevention 1

van der Straten A et al. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa. Journal of the International AIDS Society 17:19146, 2014. http://www.jiasociety.org/index.php/jias/article/view/19146/3951  

Marginalised groups

The Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe

The Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord, Timing of cART initiation in Male and Female Migrants Living with HIV in Western Europe: an observational cohort study (1997-2013), AIDS. 2017. doi: 10.1097/QAD.0000000000001411, https://www.ncbi.nlm.nih.gov/pubmed/28118205

Marginalised groups 9

Anderson J, Doyal L. Women from Africa living with HIV in London: a descriptive study. AIDS Care. 2004;16(1):95-105. http://www.ncbi.nlm.nih.gov/pubmed/14660147

Marginalised Groups 10

Baral SD et al. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. The Lancet Infectious Diseases, 13: 214-22, 2013. http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(12)70315-8/abstract

Marginalised groups 8

Blank AE, Fletcher J, Verdecias N, Garcia I, Blackstock O, Cunningham C. Factors Associated with Retention and Viral Suppression Among a Cohort of HIV+ Women of Color. AIDS Patient Care STDS. 2014. http://www.ncbi.nlm.nih.gov/pubmed/25458205

Marginalised Groups 12

Deutsch MB et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. The Lancet HIV, 2015. http://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(15)00206-4/abstract

Marginalised groups 7

Doyal, Lesley, and Jane Anderson. “HIV-positive African Women Surviving in London: Report of a Qualitative Study”. Gender and Development 14 (1): 95–104. 2006 http://www.jstor.org/stable/20461119

Marginalised groups 6

Doyal L, Anderson J'My fear is to fall in love again...' How HIV-positive African women survive in London. SocSci Med. 2005 Apr;60(8):1729-38. http://www.ncbi.nlm.nih.gov/pubmed/15686805

Marginalised groups 5

Jasseron C, Mandelbrot L, Tubiana R, et al. Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women? AIDS. 2008;22(12):1503-1511. http://www.ncbi.nlm.nih.gov/pubmed/18614874

Marginalised groups 17

Gerbier-Aublanc, M., Gosselin, A., & Group, P. S. (2016). Access to employment among African migrant women living with HIV in France: opportunities and constraints. AIDS Care, 28(8), 1058-1061. https://www.ncbi.nlm.nih.gov/pubmed/?term=Gerbier-Aublanc

Marginalised groups 18

Grant, R. M., Sevelius, J. M., Guanira, J. V., Aguilar, J. V., Chariyalertsak, S., & Deutsch, M. B. (2016). Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis. Journal of acquired immune deficiency syndromes (1999), 72(Suppl 3), S226. https://www.ncbi.nlm.nih.gov/pubmed/27429187

Marginalised groups 4

Logie, C., James, L., Tharao, W. and Loutfy, M. (2013). Associations Between HIV-Related Stigma, Racial Discrimination, Gender Discrimination, and Depression Among HIV-Positive African, Caribbean, and Black Women in Ontario, Canada. AIDS Patient Care and STDs, 27(2), pp.114-122. http://online.liebertpub.com/doi/abs/10.1089/apc.2012.0296

Marginalised Groups 11

Mixuno Y et al. Characteristics of transgender women living with HIV receiving medical care in the United States. LGBT Health, online edition. DOI: 101.1089/lgbt.2014.0099 (2015). http://www.ncbi.nlm.nih.gov/pubmed/26788671

Marginalised Groups 13

National Center for Innovation in HIV Care. Transgender Women and Pre-Exposure Prophylaxis for HIV Prevention. 2015. https://careacttarget.org/sites/default/files/file-upload/resources/PrEP%20and%20Transgender%20Women%20NCIHC%20Brief.pdf

Marginalised groups 3

Ndirangu E, Evans C. Experiences of African Immigrant Women Living with HIV in the U.K.: Implications for Health Professionals. Journal of Immigrant and Minority Health. 2009;11(2):108-114. http://www.ncbi.nlm.nih.gov/pubmed/18205047

Marginalised groups 19

Poteat, T., Scheim, A., Xavier, J., Reisner, S., & Baral, S. (2016). Global epidemiology of HIV infection and related syndemics affecting transgender people. Journal of acquired immune deficiency syndromes (1999), 72(Suppl 3), S210. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969059/

Marginalised Groups 14

Poteat T HIV in transgender populations: charted and uncharted waters. Conference on Retroviruses and Opportunistic Infections (CROI), Boston, abstract 79, 2016. Webcast of presentation: http://www.croiwebcasts.org/console/player/29575?mediaType=podiumVideo&

The Role of Structural Barriers in Risky Sexual Behavior, Victimization and Readiness to Change

Raiford JL, Hall GJ, Taylor RD, Bimbi DS, Parsons JT. The Role of Structural Barriers in Risky Sexual Behavior, Victimization and Readiness to Change HIV/STI-Related Risk Behavior Among Transgender Women. AIDS Behav. 2016;20(10):2212-21.

Marginalised groups 20

Sevelius, J. M., Keatley, J., Calma, N., & Arnold, E. (2016). 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health, 11(7-8), 1060-1075. doi:10.1080/17441692.2016.1154085 https://www.ncbi.nlm.nih.gov/pubmed/26963756

Marginalised groups 2

Syvertsen JL et al. Promise and Peril of Pre-Exposure Prophylaxis (PrEP): Using Social Science to Inform PrEP Interventions among Female Sex Workers. African Journal of Reproductive Health 2014 Sep; 18(3 0 0): 74–83. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605136/

Marginalised groups 1

Treisman K, Jones FW, Shaw E. The experiences and coping strategies of United Kingdom-based African women following an HIV diagnosis during pregnancy. J Assoc Nurses AIDS Care. 2014;25(2):145-157. http://www.ncbi.nlm.nih.gov/pubmed/23523367

Marginalised groups 15

Transgender Law Centre. Positively Trans: initial report of a national needs assessment of transgender and gender non-conforming people living with HIV. March 2016. http://transgenderlawcenter.org/programs/positively-trans/research

Marginalised groups 16

Wansom T, Guadamuz TE and Vasan S.  Transgender populations and HIV: unique risks, challenges and opportunities.  Journal of Virus Eradication.  2016;2: 87-93. http://viruseradication.com/journal-details/Transgender_populations_and_HIV:_unique_risks,_challenges_and_opportunities/

Mental health, psychological well-being and neurocognition

Mental health, psychological well-being and neurocognition 15

Taylor, T. N., Munoz-Plaza, C. E., Goparaju, L., Martinez, O., Holman, S., Minkoff, H. L., Golub, E. T. (2016). “The Pleasure Is Better as I’ve Gotten Older”: Sexual Health, Sexuality, and Sexual Risk Behaviors Among Older Women Living With HIV. Arch Sex Behav, 1-14. https://www.ncbi.nlm.nih.gov/pubmed/27220311

Mental health, psychological well-being and neurocognition 16

Rehm KE, Konkle-Parker D. Association of CD4+ T cell subpopulations and psychological stress measures in women living with HIV. AIDS Care 2017:1-5.

Mental health, psychological well-being and neurocognition 14

Antelman, G., Kaaya, S., Wei, R., Mbwambo, J., Msamanga, G., Fawzi, W. and Smith Fawzi, M. (2007). Depressive Symptoms Increase Risk of HIV Disease Progression and Mortality Among Women in Tanzania. JAIDS Journal of Acquired Immune Deficiency Syndromes, 44(4), pp.470-477. http://www.ncbi.nlm.nih.gov/pubmed/17179766

Mental health, psychological well-being and neurocognition 13

Benoit AC, Light L, Burchell AN, et al. Demographic and clinical factors correlating with high levels of psychological distress in HIV-positive women living in Ontario, Canada. AIDS Care. 2014;26(6):694-701. http://www.ncbi.nlm.nih.gov/pubmed/24215281

Mental health, psychological well-being and neurocognition 12

Blais M, Fernet M, Proulx-Boucher K, et al. Barriers to health-care and psychological distress among mothers living with HIV in Quebec (Canada). AIDS Care. 2015:1-8. http://www.ncbi.nlm.nih.gov/pubmed/25587793

Mental health, psychological well-being and neurocognition 11

Kamen, C., Arganbright, J., Kienitz, E., Weller, M., Khaylis, A., Shenkman, T., Smith, S., Koopman, C. and Gore-Felton, C. (2015). HIV-related stigma: implications for symptoms of anxiety and depression among Malawian women. African Journal of AIDS Research, 14(1), pp.67-73. http://www.ncbi.nlm.nih.gov/pubmed/25920985

Mental health, psychological well-being and neurocognition 10

Kapetanovic S, Dass-Brailsford P, Nora D, Talisman N. Mental health of HIV-seropositive women during pregnancy and postpartum period: a comprehensive literature review. AIDS Behav. 2014;18(6):1152-1173. http://www.ncbi.nlm.nih.gov/pubmed/24584458

Mental health, psychological well-being and neurocognition 9

Kotzé M, Visser M, Makin J, Sikkema K, Forsyth B. The coping strategies used over a two-year period by HIV-positive women who had been diagnosed during pregnancy. AIDS Care. 2013;25(6):695-701. http://www.ncbi.nlm.nih.gov/pubmed/23442202

Mental health, psychological well-being and neurocognition 8

Logie, C., James, L., Tharao, W. and Loutfy, M. (2013). Associations Between HIV-Related Stigma, Racial Discrimination, Gender Discrimination, and Depression Among HIV-Positive African, Caribbean, and Black Women in Ontario, Canada. AIDS Patient Care and STDs, 27(2), pp.114-122.

Mental health, psychological well-being and neurocognition 7

Maki PM, Rubin LH, Cohen M, et al. Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse human immunodeficiency virus–infected and human immunodeficiency virus–uninfected women. Menopause. 2012;19(11):1215-1223. http://www.ncbi.nlm.nih.gov/pubmed/22872013

Mental health, psychological well-being and neurocognition 6

Orza, L., Bewley, S., Logie, C., Crone, E., Moroz, S., Strachan, S., Vazquez, M. and Welbourn, A. (2015). How does living with HIV impact on women’s mental health? Voices from a global survey. Journal of the International AIDS Society, 18(Suppl 5). http://www.jiasociety.org/index.php/jias/article/view/20289

Mental health, psychological well-being and neurocognition 5

Rubin LH, Sundermann EE, Cook JA, et al. Investigation of menopausal stage and symptoms on cognition in human immunodeficiency virus-infected women. Menopause. 2014;21(9):997-1006. http://www.ncbi.nlm.nih.gov/pubmed/24496085

Mental health, psychological well-being and neurocognition 4

Sanders LB. Women's voices: the lived experience of pregnancy and motherhood after diagnosis with HIV. J Assoc Nurses AIDS Care. 2008;19(1):47-57. http://www.ncbi.nlm.nih.gov/pubmed/18191768

Mental health, psychological well-being and neurocognition 3

Sheth SS, Coleman J, Cannon T, et al. Association between depression and nonadherence to antiretroviral therapy in pregnant women with perinatally acquired HIV. AIDS Care. 2015;27(3):350-354. http://www.ncbi.nlm.nih.gov/pubmed/25616659

Mental health, psychological well-being and neurocognition 2

Treisman K, Jones FW, Shaw E. The experiences and coping strategies of United Kingdom-based African women following an HIV diagnosis during pregnancy. J Assoc Nurses AIDS Care. 2014;25(2):145-157. http://www.ncbi.nlm.nih.gov/pubmed/23523367

Mental health, psychological well-being and neurocognition 1

Willie, T., Overstreet, N., Sullivan, T., Sikkema, K. and Hansen, N. (2015). Barriers to HIV Medication Adherence: Examining Distinct Anxiety and Depression Symptoms among Women Living with HIV Who Experienced Childhood Sexual Abuse. Behavioral Medicine, pp.00-00. http://www.ncbi.nlm.nih.gov/pubmed/26010763

Miscellaneous

Miscellaneous 12

Barnes, Applied drama and theatre as an interdisciplinary field in the context of HIV/AIDS in Africa. 2014 Amsterdam: Rodopi. https://www.wits.ac.za/media/news-migration/files/DFL%207th%20Africa%20Research%20Conference%20Programme%202014.pdf

Miscellaneous 11

Campbell C & Nair Y. From rhetoric to reality? Putting HIV and AIDS rights talk into practice in a South African rural community. Cult Health Sex. 2014;16(10):1216-30. http://www.ncbi.nlm.nih.gov/pubmed/25005486

Miscellaneous 10

Chadwick. Dand Salamander Trust.  Seeking Safety: Stepping Stones in Malawi. (2013). [DVD] Malawi: COWLHA. http://steppingstonesfeedback.org/index.php/page/Resources/gb?resourceid=74

Miscellaneous 9

Dilmitis, S., Edwards, O., Hull, B., Margolese, S., Mason, N., Namiba, A., Nyambe, M., Paxton, S., Petretti, S., Ross, G., Welbourn, A. and Zakowics, A. (2012). Language, identity and HIV: why do we keep talking about the responsible and responsive use of language? Language matters. Journal of the International AIDS Society, 15(4(Suppl 2). http://www.jiasociety.org/index.php/jias/article/view/17990

Miscellaneous 8

Participatory HIV/AIDS Education Theatre in South Africa, in Dennis A. Francis (ed). 2011, Acting on HIV: Using Drama to Create Possibilities for Change, Rotterdam: Sense Publishers, pp. 1-14. https://www.sensepublishers.com/media/41-acting-on-hiv.pdf

Miscellaneous 7

Francis, D.A. (ed.) (2011) Acting on HIV : using drama to create possibilities for change. Rotterdam: Sense Publishers. https://www.sensepublishers.com/media/41-acting-on-hiv.pdf

Miscellaneous 6

Low, Katharine E, 'Creating a space for the individual: different theatre and performance-based approaches to sexual health communication in South Africa.' 2010. Journal of Applied Arts and Health. 1 (1), pp. 111-126 http://www.intellectbooks.co.uk/journals/view-Article,id=8410/

Miscellaneous 5

Oron, B., Sebuwufu, G. and Welbourn, A. (2014). Stepping Stones for Peace and Prosperity. Strategies for Hope Trust and Salamander Trust. http://www.steppingstonesfeedback.org/index.php/page/Resources/gb?resourceid=79

Miscellaneous 4

O'Sullivan, S. and Thomson, K. (1996). Positively women. Hammersmith, London: Pandora. http://trove.nla.gov.au/work/6744826?selectedversion=NBD12580176

Miscellaneous 3

Paine, K., Hart, G., Jawo, M., Ceesay, S., Jallow, M., Morison, L., Walraven, G., McAdam, K. and Shaw, M. (2002). “˜Before we were sleeping, now we are awake”: Preliminary evaluation of the Stepping Stones sexual health programme in The Gambia. African Journal of AIDS Research, 1(1), pp.39-50. http://siteresources.worldbank.org/INTGENDER/Resources/MatthewShawAJARarticle.pdf

Miscellaneous1

Robinson, S., Gardner, S., Loutfy, M., Light, L., Tharao, W., Rourke, S. B., . . . Team, O. C. S. R. (2016). Sexual behaviors among women living with HIV in Ontario, Canada. AIDS Care, 1-6. https://www.ncbi.nlm.nih.gov/pubmed/27607586

Miscellaneous 2

Welbourn, A. (1995). Stepping Stones training programme on HIV, communication and relationship skills. Oxford: Strategies for Hope. http://www.steppingstonesfeedback.org/index.php/About/Stepping_Stones_training_package/gb

Miscellaneous 1

Welbourn, A. (2014). WHO's poor consultation with patients on HIV guidance has denied women choice in drug treatment. BMJ, 348(2007), pp.f7601-f7601. http://www.bmj.com/content/348/bmj.f7601

Pregnancy

Social Support, Stigma and Antenatal Depression Among HIV-Infected Pregnant Women in South Africa

Brittain, K., Mellins, C. A., Phillips, T., Zerbe, A., Abrams, E. J., Myer, L., & Remien, R. H. (2017). Social Support, Stigma and Antenatal Depression Among HIV-Infected Pregnant Women in South Africa. AIDS Behav, 21(1), 274-282. doi:10.1007/s10461-016-1389-7, https://www.ncbi.nlm.nih.gov/pubmed/27052843

Pregnancy and linkage to care among women diagnosed with HIV

FitzHarris, L. F., Hollis, N. D., Nesheim, S. R., Greenspan, J. L., & Dunbar, E. K. (2017). Pregnancy and linkage to care among women diagnosed with HIV infection in 61 CDC-funded health departments in the United States, 2013. AIDS Care, 1-8. doi:10.1080/09540121.2017.1282107, https://www.ncbi.nlm.nih.gov/pubmed/28132520

HIV-related stigma in pregnancy

Ion, A., Wagner, A. C., Greene, S., & Loutfy, M. R. (2017). HIV-related stigma in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada. AIDS Care, 29(2), 137-144. doi:10.1080/09540121.2016.1211608, https://www.ncbi.nlm.nih.gov/pubmed/27449254

Presentation for care and antenatal management of HIV in the UK

French, C. E., Thorne, C., Byrne, L., Cortina-Borja, M., & Tookey, P. A. (2016). Presentation for care and antenatal management of HIV in the UK, 2009-2014. HIV Med. doi:10.1111/hiv.12410, https://www.ncbi.nlm.nih.gov/pubmed/27476457

Pregnancy 1

Schalkwijk, S., Colbers, A., Konopnicki, D., Greupink, R., Russel, F. G., Burger, D., & network, P. (2016). First reported use of elvitegravir and cobicistat during pregnancy. AIDS, 30(5), 807-808. https://www.ncbi.nlm.nih.gov/pubmed/26913711

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, et al. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. N Engl J Med. 2016;375(18):1726-37.

HIV-related stigma in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada

Ion A, Wagner AC, Greene S, Loutfy MR. HIV-related stigma in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada. AIDS Care. 2017;29(2):137-44.

Talking about HIV

Talking about HIV 8

AIDS Legal Network. If I knew what would happen I would have kept it to myself: Gender violence and HIV. (2012). http://www.endvawnow.org/uploads/browser/files/gender_violence_hiv__report_summary.pdf

Talking about HIV 7

Jasseron C, Mandelbrot L, Dollfus C, et al. Non-Disclosure of a Pregnant Woman’s HIV Status to Her Partner is Associated with Non-Optimal Prevention of Mother-to-Child Transmission. AIDS and Behavior.2011:1-10. http://www.ncbi.nlm.nih.gov/pubmed/22130651

Talking about HIV 6

Moses S, Tomlinson M. The fluidity of disclosure: A longitudinal exploration of women's experience and understanding of HIV disclosure in the context of pregnancy and early motherhood. AIDS Care. 2012. http://www.ncbi.nlm.nih.gov/pubmed/23110311

Talking about HIV 5

Paudel V, Baral KP. Women living with HIV/AIDS (WLHA), battling stigma, discrimination and denial and the role of support groups as a coping strategy: a review of literature. Reprod Health. 2015;12:53. http://reproductive-health-journal.biomedcentral.com/articles/10.1186/s12978-015-0032-9

Talking about HIV 4

Squire et al. Can an HIV positive woman find true love? Romance in the stories of women living with HIV. Feminism & Psychology 2003 Feb; 13(1), pp. 73–100. http://fap.sagepub.com/content/13/1/73

Talking about HIV 3

Sulstarova B, PogliaMileti F, Mellini L, Villani M, Singy P. HIV disclosure and nondisclosure among migrant women from sub-Saharan Africa living in Switzerland. AIDS Care. 2014:1-7. http://www.ncbi.nlm.nih.gov/pubmed/25297928

Talking about HIV 2

Tiendrebeogo, G., Hejoaka, F., Belem, E., Compaora, P., Wolmarans, L., Soubeiga, A. and Ouangraoua, N. (2013). Parental HIV disclosure in Burkina Faso: Experiences and challenges in the era of HAART. SAHARA-J: Journal of Social Aspects of HIV/AIDS, 10(sup1), pp.S46-S59 http://www.ncbi.nlm.nih.gov/pubmed/23808393

Talking about HIV 1

Van der Zaag, A. C. & McKnight, U. (2016) “Enacting HIV within sero-discordant relationships: a negotiation of multiplicity”. In A. Persson and S. Hughes eds. Couples with Mixed HIV Status: cross-cultural perspectives on serodiscordance (Book series: Social Aspects of HIV). Springer http://www.tandfonline.com/doi/abs/10.1080/01459740.2011.561456